Kinnate Biopharma Inc. — Form D
Kinnate Biopharma Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-12-23. The offering totals $74.5M, of which $74.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-12-23
- Form: D
- Accession: 0001797768-19-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $74.5M
- Amount sold: $74.5M
- Investors: 5
- Date of first sale: 2019-12-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-356223
Issuer
- Name: Kinnate Biopharma Inc.
- CIK: 0001797768
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 11975 EL CAMINO REAL, STE 101, SAN DIEGO, CA, 92130
- Phone: 8582994699
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Eric W Murphy | Director | San Diego, CA |
| Bret W Zbar | Director | San Diego, CA |
| Stephen W Kaldor | Executive Officer | San Diego, CA |
| Eric W Murphy | Executive Officer | San Diego, CA |
| Keith W Flaherty | Director | San Diego, CA |
| Mark W Meltz | Executive Officer | San Diego, CA |
| Jim W Tananbaum | Director | San Diego, CA |
| Dean W Mitchell | Director | San Diego, CA |
| Stephen W Kaldor | Director | San Diego, CA |
| Stephen W Kaldor | Promoter | San Diego, CA |
| Carl W Gordon | Director | San Diego, CA |
| Laurie W Smaldone Alsup | Director | San Diego, CA |
| Michael W Rome | Director | San Diego, CA |
| Nima W Farzan | Director | San Diego, CA |
| Nima W Farzan | Executive Officer | San Diego, CA |
Other filings by this issuer (2)
More